Tyler Sakraida, in Alameda, CA - Behavior Technician

Tyler Sakraida, is a Behavior Technician based in Alameda, California. Tyler Sakraida is licensed to practice in * (Not Available) (license number ) and his current practice location is 1025 Atlantic Ave Ste 101, Alameda, California. He can be reached at his office (for appointments etc.) via phone at (510) 268-8120.

NPI number for Tyler Sakraida is 1982013405 and his current mailing address is 1025 Atlantic Ave Ste 101, Alameda, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1982013405.

Contact Information

	Tyler Sakraida,
	1025 Atlantic Ave Ste 101, Alameda, CA 94501-1188
	(510) 268-8120
	Not Available

Healthcare Provider's Profile

Full Name	Tyler Sakraida
Gender	Male
Speciality	Behavior Technician
Location	1025 Atlantic Ave Ste 101, Alameda, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1982013405
Provider Enumeration Date: 08/08/2014
Last Update Date: 12/08/2021

Medical Identifiers

Medical identifiers for Tyler Sakraida such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1982013405	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101Y00000X	Counselor	CG60488055 (Washington)	Secondary
106S00000X	Behavior Technician	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tyler Sakraida is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tyler Sakraida, 1025 Atlantic Ave Ste 101, Alameda, CA 94501-1188 Ph: () -	Tyler Sakraida, 1025 Atlantic Ave Ste 101, Alameda, CA 94501-1188 Ph: (510) 268-8120

News Archive

ZEGERID OTC approval triggers $20M milestone payment to Santarus

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009.

Scientists believe that the dog genome holds a wealth of information that will benefit human health

Recently completed genetic analysis reveals that half of the more than 300 inherited canine disorders — including a number of cancers — resemble specific diseases of man; many scientists believe that the dog genome holds a wealth of information that will benefit human health.

Parasol Financial & Insurance Solutions offers disability insurance for dentists

According to statistics recently released by the American Council of Life Insurers, one third of all Americans between the ages 35 and 65 will become disabled for more than 90 days.

UC San Diego physicians develop potential new therapy for critical limb ischemia

Bioengineers and physicians at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs and leads to an estimated 230,000 amputations every year in North America and Europe alone to prevent the spread of infection and tissue death.

Vanderbilt researcher receives Waxman Foundation's award for B-cell lymphoma study

Scott Hiebert, Ph.D., of Vanderbilt University was awarded a $25,000 grant from the Samuel Waxman Cancer Research Foundation to further his research in abnormal BCL6 overexpression, which occurs in a common B-cell lymphoma.

Tyler Sakraida, - Counselor in Alameda, CA